Medeon Biodesign (6499) — Free Cash Flow Generation Index

Latest as of March 2022: 0.32x

Medeon Biodesign (6499) has a Free Cash Flow Generation Index of 0.32x as of March 2022. Free cash flow of NT$19.62 Million represents 0% of operating cash flow (NT$60.74 Million). See 6499 working capital ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.32x

Free Cash Flow / Operating CF

Free Cash Flow

NT$19.62 Million

TWD

Operating Cash Flow

NT$60.74 Million

TWD

Capital Expenditures

NT$41.12 Million

TWD

Medeon Biodesign Free Cash Flow Generation Index (2018–2018)

Historical FCF Generation Index trend for Medeon Biodesign across 1 annual periods. Explore cash flow to debt ratio of Medeon Biodesign to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Medeon Biodesign (2018–2018)

Year-by-year Free Cash Flow Generation Index for Medeon Biodesign. For the full company profile including market capitalisation, see Medeon Biodesign stock valuation.

Year	FCG Index	Free Cash Flow (TWD)	Operating CF	Capital Expenditures	YoY Change
2018	0.83x	NT$267.58 Million	NT$322.05 Million	NT$51.14 Million	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).